Cancer Prevention and Vitamin A

The events observed in the beta-carotene experiment ("Cancer Prevention," Hot Papers, The Scientist, 12[10]:11, May 11, 1998) were interesting but not unexpected. While the beta-carotene and vitamin A were given at a good dosage (30 mg beta-carotene and 25,000 IU of vitamin A), there is no indication that any of the other vitamins were supplied to the subjects. It's likely that they only had the trivial amounts specified in the RDA. The choice of dosage for their study was probably based on mo

Written byAlan Nixon
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The events observed in the beta-carotene experiment ("Cancer Prevention," Hot Papers, The Scientist, 12[10]:11, May 11, 1998) were interesting but not unexpected. While the beta-carotene and vitamin A were given at a good dosage (30 mg beta-carotene and 25,000 IU of vitamin A), there is no indication that any of the other vitamins were supplied to the subjects. It's likely that they only had the trivial amounts specified in the RDA. The choice of dosage for their study was probably based on mouse data. However, mice produce about two to four grams (based on a 70 kg man) per day of vitamin C, which is probably essential to the anticancer activity of the beta-carotene and vitamin A. I'll bet if the human subjects had been given three to five grams per day of vitamin C, the results would have been different and favorable.

The fact that mice and rats (and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies